No Data
No Data
Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Top-rated Biotechs With Negative Enterprise Values
Nkarta to Participate in March Investor Conferences
Leerink Partners Maintains Nkarta(NKTX.US) With Buy Rating, Announces Target Price $7
Nkarta (NKTX) Gets a Buy From Leerink Partners
Insider Sale: See Remarks of $NKTX (NKTX) Sells 8,638 Shares
Unlock the Full List